Immune-mediated hemolytic anemia (IMHA) is a common cause of morbidity and mortality in dogs. Infection, neoplasia, and other triggers may contribute to the development of IMHA in susceptible patients. Unidentified underlying triggers likely contribute to treatment failure. The learning objectives of this session are to: 1) Review evidence for infection and other comorbidities as triggers for IMHA 2) Identify clues in a given case context that help determine what you should be screening for in an individual patient 3) Review data from a recent AKC Canine Health Foundation study that illustrate how to optimize detection of vector borne disease agents commonly associated with immune-mediated disease Running time: 1 hour Fee: Free for Premium Membership subscribers or pay-per-view ($28)

You might also like

Tick Borne Infectious Diseases In North America: Clinical and Zoonotic Implications

01/09/2023

Tick-transmitted organisms can induce a spectrum of disease manifestations in dogs and people that r...

Read More

A Clinical Genetics Approach to Understanding Genetic, Multiplex and Health Testing

01/09/2023

The increasing availability of genetic screening tests, DNA tests, and now multiplex test panels als...

Read More

A Genetic Predisposition to Infections

01/09/2023

Why might an animal with an infection fail to respond to treatment? Why might an animal develop an...

Read More

The Increasing Threat of Canine Leptospirosis - Keys to Diagnosis, Therapy & Prevention

01/09/2023

Over recent years, leptospirosis has received increased attention regarding its emergence and spread...

Read More

What the Flu! Protecting dogs and communities from canine influenza virus

01/09/2023

Canine influenza viruses (CIV) have become established in North America and this has resulted in lar...

Read More

The Spay / Neuter Conundrum in Dogs: Breed and Body Size-Specific Guidelines

01/09/2023

The practice of early spay / neuter for companion dogs not intended for breeding has been standard f...

Read More